▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Rollins Q1 24 Earnings Conference Call At 8:30 AM ET

By RTTNews Staff Writer ✉ | Published: 4/25/2024 7:33 AM ET |

Rollins, Inc. (ROL) will host a conference call at 8:30 AM ET on April 25, 2024, to discuss Q1 24 earnings results.

To access the live webcast, log on to https://www.rollins.com/news-events/ir-calendar

To listen to the call, dial 1-877-869-3839 (US) or +1-201-689-8265 (International), with conference ID 13745380.

For comments and feedback contact: editorial@rttnews.com

Business News

Biotech Stocks Facing FDA Decision In April 2024

Biotech Stocks Facing FDA Decision in March 2024

Biotech Stocks Facing FDA Decision In November 2023

AbbVie To Collaborate With Gilgamesh To Develop Next-Gen Psychiatric Therapies

Mt. Capra Recalls Goat Milk Formula Recipe Kit, Urges Not To Use As Infant Formula

Amazon, Microsoft, Pfizer To Invest Billions In French Projects

Western Mixers Recalls Yogurt Covered Pretzels

Novartis' Scemblix Gets Breakthrough Designation For Chronic CML

CPSC Recalls: UTVs, Snowmobiles, Wall Ovens, Chairs, Toy Pinwheels, Nightgowns

Texas Pecan Recalls Select Nuts, Snack Mixes, Seeds, Snack Sticks

GM To End Chevy Malibu Production

Uber Q1 Net Loss Sharply Widens, Misses Estimates

AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide

Rollins Q1 24 Earnings Conference Call At 8:30 AM ET

AbbVie To Collaborate With Gilgamesh To Develop Next-Gen Psychiatric Therapies

Mt. Capra Recalls Goat Milk Formula Recipe Kit, Urges Not To Use As Infant Formula

Amazon, Microsoft, Pfizer To Invest Billions In French Projects

Western Mixers Recalls Yogurt Covered Pretzels

Novartis' Scemblix Gets Breakthrough Designation For Chronic CML

CPSC Recalls: UTVs, Snowmobiles, Wall Ovens, Chairs, Toy Pinwheels, Nightgowns

Texas Pecan Recalls Select Nuts, Snack Mixes, Seeds, Snack Sticks

GM To End Chevy Malibu Production

Uber Q1 Net Loss Sharply Widens, Misses Estimates

AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide

Novavax Stock More Than Doubles On Deal With Sanofi To Co-commercialize Covid-19 Vaccine

Shopify Tanks 19% On Gross Margin Outlook

Constellation Energy Reaffirms FY24 Operating Earnings Outlook - Update

Merck's Phase 3 Trial Of KEYTRUDA Plus Chemotherapy In Endometrial Cancer Fails To Meet Primary Goal

SAIC Secures $232 Mln U.S. Army Contract To Develop Electronic Warfare Systems

Mitsubishi Motors FY23 Net Profit Down; Sees Weak Profit, Higher Sales In FY24

Novavax Q1 Loss Narrows, Beats Estimates; Revises Down Annual Revenue Guidance Below View - Update

AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide

Novartis' Scemblix Gets Breakthrough Designation For Chronic CML

Moderna: FDA Delays BLA Review Of RSV Vaccine MRNA-1345

TELUS Corporation Q1 Profit Down; Sets Dividend - Update

Merck' Keytruda Receives Approval From Health Canada For Biliary Tract Carcinoma In Adults

Western Mixers Recalls Yogurt Covered Pretzels

MKS Instruments Inc. Q1 Earnings Summary

LifeStance Health Group, Inc. Q2 Loss Decreases, Beats Estimates

ZEEKR Intelligent Announces IPO Of 21 Mln ADSs At $21/ADS

First American Financial's Subsidiary Buys Wisconsin Title Service's Subsidiary, Plants

Fulcrum Therapeutics Stock Climbs In Pre-market On License Deal With Sanofi For Losmapimod

CleanSpark Appoints Scott Garrison As COO And Taylor Monnig As CTO

RumbleOn Posts Narrower Loss From Cont. Ops. In Q1

Microsoft To Invest $3.3 Bln To Accelerate Wisconsin's AI Infrastructure, Economic Growth

OppFi Inc. Q1 Profit Rises, Beats Estimates; Lifts Annual EPS Above View - Update

AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide

Biocryst Pharma's Orladeyo Approved In Mexico For Hereditary Angioedema Attacks